Primary care management of chronic obstructive pulmonary disease: An integrated goal-directed approach

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 2, 2010, Pages 83-88

  Braman, Sidney S ^a   Lee, David W ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Chronic care model; Chronic obstructive pulmonary disease; Integrated care; Primary care

Indexed keywords

CASE MANAGER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY HEALTH NURSING; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; INTEGRATIVE MEDICINE; LONG TERM CARE; PARAMEDICAL PERSONNEL; PRIMARY MEDICAL CARE; QUALITY OF LIFE; REHABILITATION CENTER; REVIEW;

DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; MODELS, ORGANIZATIONAL; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF HEALTH CARE; QUALITY OF LIFE;

EID: 76449092285     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283354981     Document Type: Review

References (64)

1. Mannino DM, Braman SS. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4:502-506.
2. Foster JA, Yawn BP, Maziar A, et al. Enhancing COPD management in primary care settings. Med Gen Med 2007; 9:24.
3. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555.
4. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946.
5. Halbert RJ, Isonaka S. International Primary Care Respiratory Group (IPCRG) Guidelines for the Management of Chronic Respiratory Diseases. Prim Care Respir J 2006; 15:13-19.
6. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveill Summ 2002; 51:1-16.
7. Calverley PM. COPD: early detection and intervention. Chest 2000; 117:365S-371S.
8. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20:799-805.
9. Barr RG, Celli B, Martinez F, et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment survey. Am J Med 2005; 118:1415 e9-1415 e17.
10. Emphysema Foundation for Our Rights to Survive. COPD: challenging symptoms, stigma and stereotypes. http://www.emphysema.net/Survey- Fact-Sheet.htm. 2006.
11. Ferguson GT, Enright PL, Buist S, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000; 117:1146-1161.
12. Confronting COPD in America. http://www.lungusa.org/atf/cf/%7B7A8D 42C2-FCCA-4604-8ADE7F5D5E762256%7D/EXESUM.PDF. 2001.
13. Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest 2006; 130:1844-1850.
14. Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored screener questionnaire for COPD. COPD 2008; 5:85-95.
15. Cazzola M, MacNee W, Martinez FJ. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31:416-468.
16. Tinkelman DG, Price D, Nordyke RJ, et al. COPD screening efforts in primary care: what is the yield? Prim Care Respir J 2007; 16:41-48.
17. Lin K, Watkins B, Johnson T, et al. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the US preventive services task force. Ann Intern Med 2008; 18:535-543.
18. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009; 274:271-332.
19. Van Schayck CP, Loozen JM, Wagena E, et al. Detecting patients at a high risk of developing obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002; 324:1370.
20. Enright P. Spirometers' technological evolution spurs increased confidence in results. Four generations of advances enable more useful diagnoses for asthma, emphysema or tuberculosis. Occup Health Saf 1994; 6:81-82; 84, 97.
21. Miller MR, Hankinson J, Brusasco V, et al. Standardization of spirometry. Eur Respir J 2005; 26:319-338.
22. Levy ML, Quanjer PH, Booker R, et al. Diagnostic spirometry in primary care. Proposed standards for general practice compliant with American Thoracic Society and European Thoracic Society recommendations. Prim Care Respir J 2009; 18:130-147.
23. Buffels J, Degryse J, Heyrman J, et al. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO study. Chest 2004; 125:1394-1399.
24. Perez-Padilla R, Vollmer WM, Vázquez-García JC, et al., for the BOLD and PLATINO study groups. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis 2009; 13:387-393.
25. Smoking-attributable mortality, years of potential life lost, and productivity losses: United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008; 57:1226-1228.
26. Anthonisen N, Skeans M, Wise R, et al. The effects of smoking cessation intervention on 14.5 year mortality: a randomized clinical trial. Ann Intern Med 2005; 142:233-239.
27. Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med 2006; 144:381-389.
28. Au DH, Bryson CL, Chien JW, et al. The effects of smoking cessation and the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med 2009; 24:457-463.
29. Chinn S, Jarvis D, Melotti R, et al. Smoking cessation, lung function and weight gain: a follow-up study. Lancet 2005; 365:1629-1635.
30. Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. www.surgeongeneral.gov/tobacco/ treating-tobacco-use08.pdf
31. Centers for Disease Control and Prevention. Recommended adult immunization schedule: United States, 2009. MMWR Morb Mortal Wkly Rep 2008; 57(53).
32. Dransfield M, Nahm M, Han M, et al. Superior immune response to proteinconjugate versus free pneumococcal polysaccride vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180:499-505.
33. Poole PJ, Chacko E, Wood-Barker RW, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006:CD002733.
34. Calverley PM, Anderson JA, Celli B, et al., TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775-789.
35. Tashkin DP, Celli B, Senn S, et al., UPLIFT study investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359:1543-1544.
36. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57:847-852.
37. Soler-Cataluña JJ, Martínez-García MA, RománSánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60:925-931.
38. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:367-370.
39. Puhan MA, Scharplatz M, Troosters T, Steuer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality. Respir Res 2005; 6:54.
40. Schols AM, Wouters EF. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21:753-762.
41. Weisburg J, Wanger J, Olson J, et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest 2002; 121:1070-1078.
42. Nocturnal Oxygen Therapy Trial group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93:391-398.
43. Centers for Medicare and Medicaid Services. Decision memo for home use of oxygen. Washington DC: US Government Printing Office; 2006. CMMS Publication CAG-00296N.
44. Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007; 176:343-349.
45. Chaouat A, Weitzenblum E, Krieger J, et al. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151:82-86.
46. Fletcher EC, Scott D, Qian W, et al. Evolution of nocturnal oxyhemoglobin desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mmHg. Am Rev Respir Dis 1991; 144:401-405.
47. Institute of Medicine. Improving the 21st century health care system. In: crossing the quality chasm: a new health system for the 21st century. Washington D.C.: The National Academies Press. 2001. pp. 23-38.
48. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996; 74:511-544.
49. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illnesses. JAMA 2002; 288:1775-1779.
50. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illnesses: the chronic care model (Part 2). JAMA 2002; 288:1909-1914.
51. Adams SG, Smith PK, Allen PF, et al. Systematic review of the chronic care model in chronic obstructive pulmonary disease in prevention and management. Arch Intern Med 2007; 167:551-561.
52. O'Reilly J, Williams AE, Holt K, et al. Evaluation of incidence of symptom: and healthcare-defined exacerbations. Prim Care Respir J 2006; 15:346-353.
53. Taylor SJC, Candy B, Bryar R, et al. Effectiveness in innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: a review of evidence. BMJ 2005; 331:485-491.
54. Farrero E, Escarrabill J, Prats E, et al. Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy. Chest 2001; 119:364-369.
55. Ostbye T. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med 2005; 3:209-214.
56. Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care survey: 2005 summary. Adv Data 2007; 387:1-39.
57. Howard R, Sanders R, Lydall-Smith SM. The implementation of restoring health: a chronic disease model to decrease acute healthcare utilization. Chron Respir Dis 2008; 5:133-141.
58. Hopkinson NS. Chronic obstructive pulmonary disease outreach services in the community. Clin Pulm Med 2007; 14:346-349.
59. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalizations for exacerbations in COPD patients. Eur Resp J 2006; 28:123-130.
60. Lemmens KM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med 2009; 103:607-691.
61. Koff PB, Jones RH, Cashman JM, et al. Proactive integrated care improves quality of life in patients with COPD. Eur Resp J 2009; 33:1031-1038.
62. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific selfmanagement intervention. Arch Intern Med 2003; 163:585-591. (Pubitemid 36314346)
63. Gadoury MA, Schwartzmann K, Rouleau M, et al. Self-management reduces both short and long-term hospitalization in COPD. Eur Respir J 2005; 26:853-857.
64. Hardin KA, Meyers F, Louie S. Integrating palliative care in severe chronic obstructive lung diasease. COPD 2008; 5:207-220.